Linda A. Barbour, MD, MSPH, FACP, Receives American Diabetes Association’s 2018 Norbert Freinkel Award


Michelle Kirkwood

Arlington, Virginia
June 7, 2018

Linda (Lynn) A. Barbour, MD, MSPH, FACP, has been selected to receive the American Diabetes Association’s® (ADA’s) 2018 Norbert Freinkel Award, given in memory of Norbert Freinkel, a dedicated investigator and industry thought leader. The Norbert Freinkel Award honors a researcher who has made outstanding contributions—including scientific publications and presentations—to the understanding and treatment of diabetes in pregnancy. Dr. Barbour will be recognized with this honor during the ADA’s 78th Scientific Sessions, June 22-26, 2018, at the Orange County Convention Center in Orlando. She will deliver her Norbert Freinkel Award Lecture, “Metabolic Culprits in Obese Pregnancies and Gestational Diabetes: Big Babies, Big Twists, Big Picture,” on Saturday, June 23. 

Dr. Barbour is a clinician/translational scientist in the management of obesity in pregnancy and gestational diabetes, and a tenured Professor in Endocrinology, Metabolism and Diabetes and Maternal-Fetal Medicine at the University of Colorado School of Medicine. She is the Medical Director of the Obstetrics Diabetes and High-Risk Clinics at the University of Colorado’s University Hospital and serves on the Editorial Board for Diabetes Care.   

Previously a CME Director for the University of Colorado, Dr. Barbour now teaches medicine and obstetrics to medical students and supervises treatment for most mothers with type 1 and type 2 diabetes in the hospital. She is a dedicated mentor for junior investigators across neonatology, maternal-fetal medicine and endocrinology. She also helped to build a Colorado translational research program in Maternal and Child Metabolic Health.  

“Congratulations and thank you, Dr. Barbour, for your exceptional work in understanding insulin resistance and maternal/fetal health,” said the ADA’s 2018 President of Health Care and Education, Felicia Hill-Briggs, PhD, ABPP. “Your work has provided new understandings of diabetes in pregnancy, as well as vital tools to treat and prevent diabetes in pregnant women around the world.”

Dr. Barbour has made several seminal observations on the hormonal and signaling changes that increase insulin resistance during pregnancy, as well as the intrauterine and dietary factors that contribute to nutrient excess and affect newborn body composition. Her NIH- and ADA-funded studies have prompted guideline changes to improve maternal/fetal health, and she has published more than 100 manuscripts, book chapters and guidelines. 

The American Diabetes Association’s 78th Scientific Sessions, to be held June 22-26, 2018, at the Orange County Convention Center in Orlando, is the world’s largest scientific meeting focused on diabetes research, prevention and care. During the five-day meeting, more than 16,000 health care professionals from around the world will have exclusive access to more than 3,000 original diabetes research presentations, participate in provocative and engaging exchanges with leading diabetes experts, and can earn Continuing Medical Education (CME) or Continuing Education (CE) credits for educational sessions. The program is grouped into eight theme areas: Acute and Chronic Complications; Behavioral Medicine, Clinical Nutrition, Education and Exercise; Clinical Diabetes/Therapeutics; Epidemiology/Genetics; Immunology/Transplantation; Insulin Action/Molecular Metabolism; Integrated Physiology/Obesity; and Islet Biology/Insulin Secretion. Felicia Hill-Briggs, PhD, ABPP, President of Health Care and Education, will deliver her address, “The American Diabetes Association in the Era of Health Care Transformation,” on Saturday, June 23, and Jane E.B. Reusch, MD, President of Medicine and Science, will present her address, “24/7/365 – Lifetime with Diabetes,” on Sunday, June 24. In total, the 2018 Scientific Sessions includes 375 oral presentations; 2,117 poster presentations, including 47 moderated poster discussions; and 297 published-only abstracts. Join the Scientific Sessions conversation on social media using #2018ADA.

About the American Diabetes Association

Nearly half of American adults have diabetes or prediabetes; more than 30 million adults and children have diabetes; and every 21 seconds, another individual is diagnosed with diabetes in the U.S. Founded in 1940, the American Diabetes Association (ADA) is the nation’s leading voluntary health organization whose mission is to prevent and cure diabetes, and to improve the lives of all people affected by diabetes. The ADA drives discovery by funding research to treat, manage and prevent all types of diabetes, as well as to search for cures; raises voice to the urgency of the diabetes epidemic; and works to safeguard policies and programs that protect people with diabetes. In addition, the ADA supports people living with diabetes, those at risk of developing diabetes, and the health care professionals who serve them through information and programs that can improve health outcomes and quality of life. For more information, please call the ADA at 1-800-DIABETES (1-800-342-2383) or visit Information from both of these sources is available in English and Spanish. Find us on Facebook (American Diabetes Association), Twitter (@AmDiabetesAssn) and Instagram (@AmDiabetesAssn)